COGT · Cogent Biosciences, Inc. · Executive Compensation

$30.87 -0.15 (-0.48%) At close · Oct 5

Russell 2000 member Rebalance outlook locked

Market Cap

$5.62B

173.52M

Volume · Oct 5 1.79M Avg daily vol (3M) 1.96M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Andrew Robbins	Chief Executive Officer	$724,554	$21,600	$12,993,250	$13,447,680	$561,600	$14,000	$27,762,684
Jessica Sachs	Chief Medical Officer	$549,389	$12,342	$4,535,250	$3,746,304	$320,892	$14,000	$9,178,177
John Robinson	Chief Scientific Officer	$532,035	$11,952	$4,535,250	$3,746,304	$310,756	$14,000	$9,150,297
Cole Pinnow	Chief Commercial Officer	$482,266	$9,568	$4,535,250	$3,549,696	$248,768	$14,000	$8,839,548
John Green	Chief Financial Officer	$510,677	$11,467	$3,965,750	$3,746,304	$298,131	$14,000	$8,546,329

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Andrew Robbins	Chief Executive Officer	$692,000	—	—	$3,734,610	$477,480	$13,800	$4,917,890
Cole Pinnow	Chief Commercial Officer	$265,385	$50,000	$262,980	$3,263,610	$127,769	—	$3,969,744
Jessica Sachs	Chief Medical Officer	$527,436	—	—	$1,018,530	$272,948	$13,800	$1,832,714
John Robinson	Chief Scientific Officer	$510,775	—	—	$1,018,530	$264,326	$13,800	$1,807,431
John Green	Chief Financial Officer	$490,025	—	—	$1,018,530	$225,412	$13,800	$1,747,767

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Andrew Robbins	Chief Executive Officer	$656,098	$393,659	$1,873,200	$4,962,615	—	$13,200	$7,898,772
Jessica Sachs	Chief Medical Officer	$507,150	$253,575	$713,600	$1,512,416	—	$13,200	$2,999,941
John Robinson	Chief Scientific Officer	$491,130	$245,565	$713,600	$1,512,416	—	$13,200	$2,975,911

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Andrew Robbins	Chief Executive Officer	$624,283	$344,920	—	$3,409,773	—	$12,200	$4,391,176
Jessica Sachs	Chief Medical Officer	$482,558	$177,744	—	$1,235,425	—	$12,200	$1,907,927
John Robinson	Chief Scientific Officer	$454,178	$167,348	—	$1,235,425	—	$12,200	$1,869,151

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jessica Sachs	Chief Medical Officer	$415,769	$167,868	—	$3,213,956	—	$11,600	$3,809,193
John Robinson	Chief Scientific Officer	$315,481	$128,082	—	$3,017,950	—	$11,600	$3,473,113
Andrew Robbins	Chief Executive Officer	$592,648	$357,075	—	$1,901,555	—	$11,600	$2,862,878

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Andrew Robbins	Chief Executive Officer	$101,731	$65,219	—	$17,692,794	—	—	$17,859,744
John Green	Chief Financial Officer	$323,957	$440,030	—	$1,375,258	—	—	$2,139,245
Charles Wilson	Former Chief Executive Officer	$481,340	—	—	—	—	$1,315,411	$1,796,751
Jessica Sachs	Chief Medical Officer	$278,738	—	—	$115,396	—	$795,323	$1,189,457

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Charles Wilson	Former Chief Executive Officer	$543,417	$232,263	—	$941,736	—	—	$1,717,416

Executive changes

Person	Role	Change	Effective	Filed
Todd Shegog	Director	Appointed	2023-06-07	2023-06-07
Arlene M. Morris	Director	Appointed	2023-06-07	2023-06-07
Chris Cain, Ph.D.	Director	Appointed	2023-06-07	2023-06-07

Key facts CIK 1622229 CUSIP 19240Q201 13F (30d) 6 filings 6 filers Visit website Investor relations